Cargando…
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between ann...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892144/ https://www.ncbi.nlm.nih.gov/pubmed/36347992 http://dx.doi.org/10.1007/s00125-022-05826-y |
_version_ | 1784881286376062976 |
---|---|
author | Dal Canto, Elisa Elders, Petra J. M. van der Heijden, Amber A. van Ballegooijen, Adriana J. Lissenberg-Witte, Birgit I. Rutters, Femke Beulens, Joline W. J. |
author_facet | Dal Canto, Elisa Elders, Petra J. M. van der Heijden, Amber A. van Ballegooijen, Adriana J. Lissenberg-Witte, Birgit I. Rutters, Femke Beulens, Joline W. J. |
author_sort | Dal Canto, Elisa |
collection | PubMed |
description | AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. RESULTS: After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60–90 ml/min per 1.73 m(2)) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m(2)) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m(2)). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3–30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article 10.1007/s00125-022-05826-y contains peer-reviewed but unedited supplementary material. |
format | Online Article Text |
id | pubmed-9892144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98921442023-02-03 Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort Dal Canto, Elisa Elders, Petra J. M. van der Heijden, Amber A. van Ballegooijen, Adriana J. Lissenberg-Witte, Birgit I. Rutters, Femke Beulens, Joline W. J. Diabetologia Article AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. RESULTS: After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60–90 ml/min per 1.73 m(2)) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m(2)) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m(2)). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3–30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article 10.1007/s00125-022-05826-y contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2022-11-08 2023 /pmc/articles/PMC9892144/ /pubmed/36347992 http://dx.doi.org/10.1007/s00125-022-05826-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Dal Canto, Elisa Elders, Petra J. M. van der Heijden, Amber A. van Ballegooijen, Adriana J. Lissenberg-Witte, Birgit I. Rutters, Femke Beulens, Joline W. J. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title | Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title_full | Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title_fullStr | Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title_full_unstemmed | Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title_short | Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort |
title_sort | kidney function measures and cardiovascular outcomes in people with diabetes: the hoorn diabetes care system cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892144/ https://www.ncbi.nlm.nih.gov/pubmed/36347992 http://dx.doi.org/10.1007/s00125-022-05826-y |
work_keys_str_mv | AT dalcantoelisa kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT elderspetrajm kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT vanderheijdenambera kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT vanballegooijenadrianaj kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT lissenbergwittebirgiti kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT ruttersfemke kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort AT beulensjolinewj kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort |